Evaluation of suspected soft tissue lesion in the prostate bed after radical prostatectomy using 3T multiparametric magnetic resonance imaging

Magnetic Resonance Imaging

Volumn 33, Issue 4, 2015, Pages 407-412

  Cha, Dongik ^a   Kim, Chan Kyo ^a   Park, Sung Yoon ^a   Park, Jung Jae ^a   Park, Byung Kwan ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Local neoplasm recurrence; Magnetic resonance imaging; Multiparametric MRI; Prostate cancer; Prostatectomy

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; HUMAN; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; SOFT TISSUE DISEASE; T2 WEIGHTED IMAGING; TRANSRECTAL ULTRASONOGRAPHY; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MULTIMODAL IMAGING; PATHOLOGY; PREVENTION AND CONTROL; PROCEDURES; PROSTATIC NEOPLASMS; REPRODUCIBILITY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84927912530     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2014.12.003     Document Type: Article

References (28)

1. Trapasso J.G., deKernion J.B., Smith R.B., Dorey F. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol 1994, 152:1821-1825.
2. Han M., Partin A.W., Zahurak M., Piantadosi S., Epstein J.I., Walsh P.C. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003, 169:517-523.
3. Freedland S.J., Mangold L.A., Walsh P.C., Partin A.W. The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy. J Urol 2005, 174:1276-1281. [discussion 1281; author reply 1281].
4. Amling C.L., Bergstralh E.J., Blute M.L., Slezak J.M., Zincke H. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?. J Urol 2001, 165:1146-1151.
5. Loblaw D.A., Mendelson D.S., Talcott J.A., Virgo K.S., Somerfield M.R., Ben-Josef E., et al. American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol 2004, 22:2927-2941.
6. Partin A.W., Pearson J.D., Landis P.K., Carter H.B., Pound C.R., Clemens J.Q., et al. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology 1994, 43:649-659.
7. Kane C.J., Amling C.L., Johnstone P.A., Pak N., Lance R.S., Thrasher J.B., et al. Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. Urology 2003, 61:607-611.
8. Oyen R.H., Van Poppel H.P., Ameye F.E., Van de Voorde W.A., Baert A.L., Baert L.V. Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 1994, 190:315-322.
9. Scattoni V., Montorsi F., Picchio M., Roscigno M., Salonia A., Rigatti P., et al. Diagnosis of local recurrence after radical prostatectomy. BJU Int 2004, 93:680-688.
10. Saleem M.D., Sanders H., Abu El Naser M., El-Galley R. Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy. Urology 1998, 51:283-286.
11. Panebianco V., Sciarra A., Lisi D., Galati F., Buonocore V., Catalano C., et al. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Eur J Radiol 2012, 81:700-708.
12. Cirillo S., Petracchini M., Scotti L., Gallo T., Macera A., Bona M.C., et al. Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 2009, 19:761-769.
13. Sciarra A., Panebianco V., Salciccia S., Osimani M., Lisi D., Ciccariello M., et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008, 54:589-600.
14. Liauw S.L., Pitroda S.P., Eggener S.E., Stadler W.M., Pelizzari C.A., Vannier M.W., et al. Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2013, 85:378-384.
15. Rischke H.C., Schafer A.O., Nestle U., Volegova-Neher N., Henne K., Benz M.R., et al. Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil. Radiat Oncol 2012, 7:185.
16. Djavan B., Milani S., Fong Y.K. Benign positive margins after radical prostatectomy means a poor prognosis-pro. Urology 2005, 65:218-220.
17. Shah R., Bassily N., Wei J., Mucci N.R., Montie J.E., Sanda M.G., et al. Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors. Urology 2000, 56:721-725.
18. Paul R., Hoppmann M., van Randenborgh H., Kubler H., Alschibaja M., Gunther M., et al. Residual benign prostatic glands at the urethrovesical anastomosis after radical retropubic prostatectomy: prediction and impact on disease outcome. Eur Urol 2004, 46:321-326.
19. Roy C., Foudi F., Charton J., Jung M., Lang H., Saussine C., et al. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. AJR Am J Roentgenol 2013, 200:W361-W368.
20. Panebianco V., Barchetti F., Sciarra A., Musio D., Forte V., Gentile V., et al. Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging. Eur Radiol 2013, 23:1745-1752.
21. Mottet N., Bellmunt J., Bolla M., Joniau S., Mason M., Matveev V., et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011, 59:572-583.
22. Kim C.K., Park B.K., Lee H.M., Kim S.S., Kim E. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR Am J Roentgenol 2008, 190:1180-1186.
23. Kim C.K., Park B.K., Kim B. Diffusion-weighted MRI at 3T for the evaluation of prostate cancer. AJR Am J Roentgenol 2010, 194:1461-1469.
24. Djavan B., Sesterhann I., Hruby S., Susani M., Haitel A., Etemad, et al. Benign prostatic glands in the surgical margin of radical retropubic Prostatectomies: redefining PSA nadir. J Urol 2000, 163A:624.
25. Pound C.R., Partin A.W., Eisenberger M.A., Chan D.W., Pearson J.D., Walsh P.C. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999, 281:1591-1597.
26. Silverman J.M., Krebs T.L. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR Am J Roentgenol 1997, 168:379-385.
27. Sella T., Schwartz L.H., Hricak H. Retained seminal vesicles after radical prostatectomy: frequency, MRI characteristics, and clinical relevance. AJR Am J Roentgenol 2006, 186:539-546.
28. Casciani E., Polettini E., Carmenini E., Floriani I., Masselli G., Bertini L., et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. AJR Am J Roentgenol 2008, 190:1187-1192.